Evidence mapPaperPMID 41683713Full record

ArticleInternational journal of molecular sciences2026

Single-Cell RNA-Seq Profiling of Transposable Element Expression in Human Peripheral Blood Cells During Viral Infections.

Oleg D Fateev, Vasily E Akimov, Olga V Glushkova, Aleksandr V Bolbat, Azat V Abdullatypov, Olga A Antonova, Vladimir V Shiryagin, Nikolai A Bugaev-Makarovsky, Vladimir S Yudin, Anton A Keskinov and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Oleg D FateevFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0002-5976-4422
Vasily E AkimovFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0009-0003-0380-8144
Olga V GlushkovaFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0002-0257-6439
Aleksandr V BolbatFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.
Azat V AbdullatypovFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.
Olga A AntonovaFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.
Vladimir V ShiryaginFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.
Nikolai A Bugaev-MakarovskyFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0003-0647-5421
Vladimir S YudinFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0002-9199-6258
Anton A KeskinovFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.
Sergei M YudinFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0002-7942-8004
Dmitriy V SvetlichnyFederal State Budgetary Institution "Center for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical-Biological Agency (FSBI "CSP" of FMBA of Russia), Pogodinskaya str. 10, bld. 1, Moscow 119435, Russia.ORCID 0000-0002-3776-9871
Veronika I SkvortsovaFederal Medical-Biological Agency (FMBA of Russia), Volokolamskoye Shosse, 30, Moscow 119121, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transposable elements (TEs) are key regulators of immunity in both health and disease. It has been proven that the activity and transcriptional expression levels of TEs increase during viral infections, correlating with the antiviral response. This study investigates non-LTR TE (LINE, SINE, and SVA) transcriptomic signatures in human PBMCs during infections caused by influenza A virus, HIV, and SARS-CoV-2 (Delta/Omicron variants) using single-cell RNA sequencing (scRNA-seq) data from 98 patients. In the HIV and SARS-CoV-2 patient cohorts, unique cell-specific TE expression patterns were identified that allow for the differentiation of disease severity, prediction of disease progression, and assessment of the therapy's efficacy. The expression of LINE elements was found to be more dependent on the nature and course of the disease than that of SINE elements. The most variable TE expression profile was observed in precursor cytotoxic T-lymphocytes (T CD8+ Naive cells), which depended on the virus type and the severity of the viral disease. For this cell type, a bioinformatic analysis of the co-expression regulation of TE transcriptional networks and transcription factors during viral infections was performed. This analysis identified key players among those most involved in virus-specific responses, which could serve as diagnostic biomarkers or therapeutic targets for treating diseases caused by influenza A virus, HIV, and SARS-CoV-2. This work confirms the involvement of non-LTR TEs in mediating antiviral responses. Further research into the mechanisms of TE participation in antiviral defense is necessary to recommend them as potential biomarkers for the diagnosis, monitoring, and assessment of antiviral therapy, or as therapeutic targets for viral infections of various origins.

Indexed as

COVID-19DNA Transposable ElementsHIV InfectionsInfluenza, HumanLeukocytes, MononuclearVirus DiseasesGene Expression ProfilingHumansInfluenza A virusRNA-SeqSARS-CoV-2Single-Cell AnalysisSingle-Cell Gene Expression AnalysisTranscriptomeDNA Transposable ElementsCOVID-19HIVinfluenza AscRNA-seqtransposable elementsviral infection

Identifiers

PMID41683713
PMCPMC12898442

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.